<p>In this episode of <strong>Real Cancer Talk </strong>recorded at the annual convening of the <strong>Robert A. Winn Excellence in Clinical Trials program, Dr. Robert Winn</strong> spoke with Winn CDA Cohort 3 scholars <strong>Maliha Nusrat, M.D., M.S.</strong>, from Memorial Sloan Kettering Cancer Center and <strong>Blessie E. Nelson, M.M.B.B.S., D.M.R.T.</strong>, from MD Anderson Cancer Center, about what they see as the most pressing issue in the realm of clinical trials and cancer research today. Dr. Nusrat and Dr. Nelson also go in-depth on their research into pearheading new decentralized trial designs at their institutions.</p><p>Massey Website: <a target="_blank" rel="noopener noreferrer nofollow" href="https://masseycancercenter.org">https://masseycancercenter.org</a></p><p>Facebook: <a target="_blank" rel="noopener nofollow" href="https://www.facebook.com/VCUMasseyCancerCenter">/vcumasseycancercenter</a></p><p>Instagram: <a target="_blank" rel="noopener nofollow" href="https://www.instagram.com/vcumassey/">@vcumassey</a></p><p><strong>VCU Massey Comprehensive Cancer Center</strong> is one of only 71 National Cancer Institute-designated institutions in the country that leads and shapes America's cancer research efforts. Working with all kinds of cancers, Massey conducts basic, translational and clinical cancer research, provides state-of-the-art treatments and clinical trials, and promotes cancer prevention and education. Since 1974, Massey has served as an internationally recognized center of excellence. It offers the most cancer clinical trials in Virginia and serves patients at multiple locations. Its 1,000-plus researchers, clinicians and staff members are dedicated to improving the quality of human life by developing and delivering effective means to prevent, control and ultimately cure cancer. Visit Massey online at <a target="_blank" rel="noopener noreferrer nofollow" href="http://masseycancercenter.org">masseycancercenter.org</a> or call <strong>877-4-MASSEY</strong> for more information.</p>